Morgan Cheatham

Morgan Cheatham, a venture capitalist at Bessemer and a medical student at Brown, dives into the intersection of AI and genomic medicine. He reveals how AI is revolutionizing clinical documentation and decision-making, making medicine more precise. Morgan shares insights from his research on ChatGPT's USMLE performance and discusses the hurdles of outdated payment models in healthcare. His journey highlights the blend of medical training and venture capital, emphasizing that innovation must be supported by sustainable business strategies.

Andrew Hedin and Morgan Cheatham from Bessemer Venture Partners share their insights on the future of healthcare innovation. They discuss the evolving implications of Individual Coverage Health Reimbursement Arrangements for Obamacare and how shifting employment dynamics will impact health insurance. The duo delves into the role of AI in home healthcare, improving caregiver support, and enhancing family interactions with aging relatives. Optimism shines through as they highlight emerging therapies, new payment models, and the exciting potential for startups by 2025.

Sofia Guerra and Morgan Cheatham discuss 2024 healthcare predictions including the interest of technology VCs in the healthcare sector, the proliferation of AI solutions in healthcare, evolving business models in digital health, predictions for funding and IPOs, and the potential impact of the US election on healthcare.